Management Software

Profile

Skilled intellectual property attorney with extensive

experience in a wide range of technologies and disciplines,

including medical imaging/scanning devices, gene sequencing

technology, chemical processes, pharmaceutical nanosphere

technology, biotechnology software encryptions, laser diodes,

transducers and transducer calibration systems, content

management software, military fasteners, and night-vision

technology. Proven ability to work under extreme pressure in

meeting deadlines and exceeding client expectations.

Education

J.D., Catholic University of America, Columbus School of Law 2006

M.B.A. course credits received, John F. Kennedy University

1996

B.S., Biochemistry, University of California, Davis 1991

Bar Admissions

Maryland; District of Columbia; U.S.P.T.O. (registered patent

attorney); and U.S. Court of Appeals, Federal, 10th and 11th

Circuits. Application for admission to the U.S. Court of

Appeals, 4th Circuit is currently pending.

Professional Experience

Partner Attorney, Business Law Associates, LLC, Rockville, MD

06/2009 - present

. Perform prior art analyses for multiple patent infringement

litigation involving branded and generic pharmaceuticals.

. Counsel and advise foreign intellectual property attorneys

on objective factors necessary to overcome a prima facie

showing of obviousness.

. Draft provisional and non-provisional patent applications.

. Draft trademark use/control licensing agreements.

. Advise clients on a variety of trademark licensing and

franchising issues.

. Draft freedom to operate (FTO), validity, infringement, and

patentability opinions.

. Evaluate inconsistencies and factors demonstrating

obviousness in New Drug Applications and Abbreviated New

Drug Applications, and analyzed privilege issues in

protecting communications to patent counsel for purposes of

obtaining legal advice on patentability in accordance with

In re Spalding Sports Worldwide, Inc.

Associate Attorney, Patton Boggs LLP, McLean, VA 01/2007

- 05/2009

Intellectual Property and ITC Litigation

. Drafted motions, responses, and memoranda of law at various

stages of International Trade Commission Section 337

investigation and patent litigation; performed pre-filing

investigation, including claim construction and

infringement analysis; drafted interrogatories and

responses; drafted memoranda of law analyzing best mode,

obviousness, and other patentability issues; and prepared

Markman claim charts and privilege logs.

. Played a crucial role in a Section 337 investigation into

infringement of patented biotechnology involving L-lysine

producing microorganism by Chinese manufacturers.

. Analyzed litigation-related documents, including New Drug

Applications and Abbreviated New Drug Applications, for

secondary considerations on obviousness.

. Advised clients on patentability issues, including drafting

FTO and patentability opinions and prior art search

reports.

. Successfully managed an investigation into misappropriation

of company trade secrets, including proprietary

manufacturing processes and customer lists, by former

employees.

. Drafted application amendments and responses traversing

rejections for provisional, non-provisional, and PCT

applications relating to pharmaceutical and medical imaging

innovations.

Export Compliance

. Drafted commodity jurisdiction, technical review, and

classification determination requests; technical assistance

and manufacturing license agreements; voluntary and

directed disclosures; Committee on Foreign Investment in

the U.S. (CFIUS) review requests; and Office of Foreign

Assets Control (OFAC) disclosures on behalf of clients to

various U.S. government agencies, including the Departments

of Commerce, State, Treasury, and Defense.

. Investigated, advised, and assisted a major British defense

conglomerate and the largest U.S. military security

contractor in disclosing export violations to the U.S.

Attorney's Office and Departments of Commerce and State.

. Supervised and led a team of over 40 contract attorneys in

responding to various government agency investigations and

criminal enforcement proceedings against the largest U.S.

private security contractor involving no-bid security

contracts in Iraq, Afghanistan, and Sudan.

Additional Experience

Franchisee, Burger King Corporation, 08/1992 - 04/2003

Midland Management LLC, Oakland and Central Valley, CA

. Managed administrative and operational duties, including

hiring/termination of upper management personnel, managing

regional advertising creatives, auditing unemployment,

compensation, and fringe benefits, performing P&L analyses,

and establishing rules and regulations, for seven

restaurants with over 190 employees.

Director of Graduate Studies and Senior Laboratory Technician

09/1988 - 08/1991

Departments of Endocrinology and Human Physiology,

University of California, Davis, School of Medicine, Davis,

CA

. Designed, performed, and revised research protocols for TGF

?-receptor/blocker investigations on breast cancer cell

inhibition and trigger differentiation.

. Performed day-to-day research activities for two graduate

research laboratories involving the study of progesterone

receptor activation and manic depressive/bipolar disorder.

. Specialized in sterile techniques involving cell culture,

cell line maintenance, and pituitary cell harvesting and

transfection.

Professional Affiliations

American Bar Association, Intellectual Property Section 10/2005

- present

Maryland Bar Foundation, Pro Bono Program, Member Attorney

07/2007 - present

Phi Delta Phi Honor Fraternity, President & Magistrate of Jaworski

Inn 12/2003 - 05/2006

Presentations & Papers

Hsur, M. and Mellen, M., Intersection of Export Controls and

Intellectual Property in the

Defense Industry, Patton Boggs Academy, April 12, 2008.

Hsur, M., The Use of Export Controls to Thaw Discovery During

Infringement Litigation, Export Compliance Breakfast Lecture

Series, September 23, 2008.

Hsur, M., The Attorney-Client Privilege and the Work-Product

Doctrine Series, The Pitfalls of Selective Waiver During

Government Agency Investigations, Patton Boggs Client

Memorandum, March 6, 2009.

Contact this candidate